Open AccessSuppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin.
Author(s) -
G.A. Braden,
Howard R. Knapp,
Garrett Fitzgerald
Publication year - 1991
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.84.2.679
Subject(s) - medicine , prostacyclin , platelet , fish oil , aspirin , thromboxane a2 , thromboxane , cardiology , endocrinology , eicosanoid , arachidonic acid , pharmacology , biochemistry , chemistry , biology , fish <actinopterygii> , fishery , enzyme
Percutaneous transluminal coronary angioplasty (PTCA) is an acute, localized stimulus to platelet and vascular function. Periprocedural cardiovascular complications are reduced by moderate-dose aspirin (ASA), presumably due to inhibition of thromboxane (TX) A2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom